AlphAIAlphAI — Financial news for AI agents
investing.comOCT 283 min read$TDOC

Teladoc Q3 2026 slides: margins expand as BetterHelp shifts to insurance

Teladoc Health (TDOC) reported Q3 2026 revenue of $605M, down 3% YoY but above estimates. Adjusted EBITDA grew 14% to $79.4M, with margins expanding to 13.1%. The company raised full-year guidance, focusing on insurance-based mental health services and integrated care platforms. Shares rose 6.7% to $6.88 and 8.9% after-hours to $7.49.

Original reporting
investing.com
Published Oct 28, 2026, 10:24 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 10:32 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$TDOC
Bullish
high confidence
Mentioned
$TDOC
Relevance
9/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$TDOCBullishHigh
01

Why it matters

The earnings beat and raised guidance suggest improved profitability, likely supporting short‑term price appreciation.

02

Market read

Strong earnings and guidance lift TDOC, with potential spillover to the broader telehealth sector.

03

What to watch

Convertible note maturity in 2027 and potential refinancing risk could temper upside.

Relevance 9/10Novelty 9/10Timing: after‑hours today

Background

Teladoc Health reported its Q3 2026 earnings, highlighting a shift toward higher‑margin insurance‑based mental health services.

Company-level read

Ticker impact

$TDOCBullishHigh confidence
Context

Q3 2026 results beat expectations with revenue $605M and adjusted EBITDA $79.4M, and raised full-year guidance, driving a 6.7% rise in regular trading and an 8.9% after‑hours jump.

Expected impact

upward pressure as investors price in stronger profitability and higher guidance

Evidence & confidence

Margin expansion, cash generation and a higher full‑year outlook reduce downside risk and attract buying.

Market effects

Sector

Telehealth and virtual care sector may see broader rally on improved margins and insurance shift.

Regional

U.S. healthcare stocks could benefit from Teladoc's positive earnings narrative.

Global

Limited to U.S. listed telehealth players; no immediate global macro effect.

Counterpoint

What could challenge this read

Margin gains may be temporary if user growth continues to decline; watch for future revenue pressure.

Key entities

  • company
    Teladoc Health

    U.S. listed telehealth provider (NYSE:TDOC).

Read at source← All news

StoryTeladoc reports narrower Q3 loss and raises full-year outlook

Also covered by

2 outlets

Related articles

OCT 28
$TDOCHighAI 8/10

Teladoc shares surge 9% on narrower-than-feared loss, raised outlook

Teladoc Health (TDOC) shares rose 9% after Q3 results beat expectations with a loss of -$0.15 per share vs. -$0.22 estimate, and revenue of $605.1M vs. $588.44M estimate. The company raised its full-year outlook, projecting a loss of -$0.75 to -$0.95 per share and revenue of $2.4B to $2.44B. Adjusted EBITDA increased 14% YoY to $79.4M, with the Integrated Care segment showing growth while BetterHelp declined 13% YoY.

investing.com2 min
OCT 28
$GOOGLHighAI 8/10

After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC

Alphabet (GOOGL) fell 8% after reporting Q3 revenue of $127.6B, missing EPS estimates. Microsoft (MSFT) rose 4% on strong cloud performance. ServiceNow (NOW) dropped 16% after an earnings miss. KLA (KLAC) gained 3% on strong guidance. Chipotle (CMG) rose 2% on revenue beat. Carvana (CVNA) climbed 6% on top-line beat. Teladoc (TDOC) gained 8% on smaller loss and revenue beat.

investing.com3 min
OCT 28
$TDOCHighAI 8/10

Teladoc: Q3 Earnings Snapshot

Teladoc Inc. (TDOC) reported a Q3 loss of $26.9M, or 15 cents per share, beating analyst expectations of a 23 cents per share loss. Revenue was $605.1M, exceeding forecasts of $585.5M. The company expects Q4 revenue between $569M and $615M, and full-year revenue between $2.4B and $2.44B, with a loss per share between 95 and 75 cents.

finance.yahoo.com1 min
OCT 28
$TDOCHighAI 9/10

Teladoc (NYSE:TDOC) exceeds Q3 2026 expectations, stock jumps 11.5%

Teladoc (TDOC) reported Q3 2026 revenue of $605.1M, beating estimates by 2.8%, with EPS of -$0.15, a 30% beat. Adjusted EBITDA was $79.36M, a 16.6% beat. Q4 revenue guidance of $592M is slightly below estimates, while full-year EPS and EBITDA guidance beat expectations. Operating margin improved to -4.6% from -8.3% YoY, and free cash flow margin rose to 12.5% from 10.5% QoQ.

finance.yahoo.com2 min
OCT 28
$TDOCHighAI 8/10

Teladoc Health Reports Third Quarter 2026 Results

Teladoc Health, Inc. (TDOC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Teladoc Health Reports Third Quarter 2026 Results NEW YORK, October 28, 2026 — Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended September 30, 2026 (“Third Quarter 2026”). Unless otherwis

SEC EDGAR 8-K2 min
SEP 28
$TDOCMed

Why is Teladoc stock sliding today?

Teladoc (TDOC) shares fell 2.3% to $5.95 amid leadership transition concerns. The company's CLO resigned, raising governance questions. The stock has declined since Q2 revenue missed expectations and guidance was cut. Analysts have lowered price targets, and institutional selling has increased. The broader market's decline added pressure. TDOC trades near its 52-week low of $4.40.

investing.com2 min